Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The trials for Moderna's mRESVIA vaccine, which uses the same mRNA technology as the company's Covid-19 shot, did not show ...

The CDC lowered the age for the pneumonia vaccination from 65 to 50 and recommended an extra COVID shot to some people.

It contains isolated proteins from the virus which help the immune system to fight it, but don’t contain any live pathogens (nor is it an mRNA vaccine). The Shingrix vaccine, given to prevent shingles ...

RSV, which stands for respiratory syncytial ... thanks to ongoing clinical trials of new immunizations and treatments, including mRNA vaccines that would be given to mothers who would pass ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on COVID ...

Short-term headwinds include declining COVID-19 vaccination rates and a slow ramp-up for its RSV vaccine. Of the ten new products expected by 2027, Moderna, Inc. (NASDAQ:MRNA) plans to file for ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

Moderna and Merck have started exploring a Phase 3 trial of combining mRNA-4157 and KEYTRUDA for use in cases of non-small ...